2023³âµµ ´ëÇѳ»°úÀÇ»çȸ°³ÃÖ Ãß°èÇмú´ëȸ : 2023-10-21
±³À°ÀÏÀÚ : 2023-10-21
±³À°Àå¼Ò : ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë
±³À°ÁÖÁ¦ : 2023³âµµ ´ëÇѳ»°úÀÇ»çȸ°³ÃÖ Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑ°³¿øÀÇÇùÀÇȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѳ»°úÀÇ»çȸ
´ã´çÀÚ : ±è¼º¸ñ
¿¬¶ôó : 051-321-2119
À̸ÞÀÏ : medmosquitoo@hanmail.net
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 500¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í »çÀüµî·Ï 4¸¸¿ø, ÇöÀåµî·Ï 5¸¸
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 15:00~15:30 SGLT-2 inhibitorÀÇ µîÀå°ú enavogliflozinÀÇ Ã¹°ÉÀ½ ±è¹Ì°æ ±³¼ö(ÇØ¿î´ë¹éº´¿ø)
±³À°½Ã°£ 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 15:30~16:00 Achieving target blood pressure with Fimasartan combination therapy À̼±ÇÐ ±³¼ö(ºÎ»ê´ëÇб³º´¿ø)
±³À°½Ã°£ 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 16:00~16:30 °³¿ø°¡¿¡¼ Á¢ÇÏ´Â ¿Ü°úÁúȯÀÇ ÀÀ±Þ»óȲ(Ãæ¼ö¿°,°Ô½Ç¿°,Àåõ°ø,ÀåÆó»ö) ¹Úº´¼ö ±³¼ö(¾ç»êºÎ»ê´ëº´¿ø)
±³À°½Ã°£ 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 16:30~17:00 ´ë°¡¿¡°Ô µè´Â ¿Ã¹Ù¸¥ »óºÎÀ§Àå°ü³»½Ã°æ °Ë»ç (»ðÀÔ,°üÂû,Æǵ¶¹ý) ÀÌÁØÇà ±³¼ö(¼¿ï»ï¼ºº´¿ø)
ÈÞ½Ä 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 17:00~17:15 Coffee Break ()
±³À°½Ã°£ 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 17:15~18:15 À§¿°ÀÇ ºÐ·ù¿Í ºÎÀ§¿¡ µû¸¥ È£¹ß¾Ï ±è¼ºÀº ±³¼ö(°í½ÅÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 18:15~19:15 À§ ³»½Ã°æ ¼Ò°ß°ú Á¶Á÷°Ë»çÀÇ Â÷ÀÌ –¾ç¼º, ¾Ç¼º, Atypia, Atypical glands, Atypical cells ÀÌÁØÇà ±³¼ö(¼¿ï»ï¼ºº´¿ø)
±³À°½Ã°£ 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 19:15~19:45 Holistic treatment for achieving goals in patients with T2DM ¹ÚÁ¤Çö ±³¼ö(ºÎ»ê¹éº´¿ø)
±³À°½Ã°£ 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 19:45~20:45 °£ÀåÁ¦ »ç¿ë¿øÄ¢°ú ó¹æ ÀßÇϱâ À̼º¿í ±³¼ö(À̼º¿í³»°úÀÇ¿ø)
±³À°½Ã°£ 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 20:45~21:45 ÃֽŠ¼Òȱ⠳»½Ã°æ º¸Çè û±¸ ±æ¶óÀâÀÌ ÃÖÀ±Á¾ ÀÌ»ç(´ëÇÑÀ§´ëÀå³»½Ã°æÇÐȸ)